Pharmaceutical compositions comprising monoterpenes

    公开(公告)号:US10899691B2

    公开(公告)日:2021-01-26

    申请号:US16575587

    申请日:2019-09-19

    摘要: The present invention provides a process for purifying a monoterpene or sesquiterpene having a purity greater than about 98.5% (w/w). The process comprises the steps of derivatizing the monoterpene (or sesquiterpene) to produce a monoterpene (or sesquiterpene) derivative, separating the monoterpene (or sesquiterpene) derivative, and releasing the monoterpene (or sesquiterpene) from the derivative. Also encompassed by the scope of the present invention is a pharmaceutical composition comprising a monoterpene (or sesquiterpene) having a purity greater than about 98.5% (w/w). The purified monoterpene can be used to treat a disease such as cancer. The present monoterpene (or sesquiterpene) may be administered alone, or may be co-administered with radiation or other therapeutic agents, such as chemotherapeutic agents.

    Method for converting farnesol to nerolidol in the presence of alpha-bisabolol
    68.
    发明授权
    Method for converting farnesol to nerolidol in the presence of alpha-bisabolol 有权
    在α-红没药醇存在下将法呢醇转化为橙花叔醇的方法

    公开(公告)号:US09199900B2

    公开(公告)日:2015-12-01

    申请号:US13866119

    申请日:2013-04-19

    申请人: Symrise AG

    摘要: A method for converting farnesol to nerolidol in the presence of alpha-bisabolol including providing or preparing a mixture of alpha-bisabolol, farnesol, and one or more catalysts for selective isomerization of farnesol to nerolidol in the presence of alpha-bisabolol, and converting at least a portion of the farnesol to nerolidol.

    摘要翻译: 一种在α-红没药醇存在下将法呢醇转化为橙花叔醇的方法,包括提供或制备α-红没药醇,法呢醇和一种或多种催化剂的混合物,用于在α-红嘌呤的存在下将法呢醇选择性异构化为橙花叔醇, 法尼醇至橙花叔醇的至少一部分。